162 related articles for article (PubMed ID: 23871219)
1. High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.
Iijima N; Goodwin EC; Dimaio D; Iwasaki A
Virology; 2013 Sep; 444(1-2):257-62. PubMed ID: 23871219
[TBL] [Abstract][Full Text] [Related]
2. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.
Guess JC; McCance DJ
J Virol; 2005 Dec; 79(23):14852-62. PubMed ID: 16282485
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.
Fausch SC; Da Silva DM; Rudolf MP; Kast WM
J Immunol; 2002 Sep; 169(6):3242-9. PubMed ID: 12218143
[TBL] [Abstract][Full Text] [Related]
4. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.
Hong S; Mehta KP; Laimins LA
J Virol; 2011 Sep; 85(18):9486-94. PubMed ID: 21734056
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.
Reiser J; Hurst J; Voges M; Krauss P; Münch P; Iftner T; Stubenrauch F
J Virol; 2011 Nov; 85(21):11372-80. PubMed ID: 21849431
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.
Da Silva DM; Movius CA; Raff AB; Brand HE; Skeate JG; Wong MK; Kast WM
Virology; 2014 Mar; 452-453():279-86. PubMed ID: 24606705
[TBL] [Abstract][Full Text] [Related]
7. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
Nimako M; Fiander AN; Wilkinson GW; Borysiewicz LK; Man S
Cancer Res; 1997 Nov; 57(21):4855-61. PubMed ID: 9354449
[TBL] [Abstract][Full Text] [Related]
9. Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells:
Song J; Lang F; Zhao N; Guo Y; Zhang H
Front Immunol; 2018; 9():2437. PubMed ID: 30410487
[TBL] [Abstract][Full Text] [Related]
10. The biological properties of E6 and E7 oncoproteins from human papillomaviruses.
Ghittoni R; Accardi R; Hasan U; Gheit T; Sylla B; Tommasino M
Virus Genes; 2010 Feb; 40(1):1-13. PubMed ID: 19838783
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
[TBL] [Abstract][Full Text] [Related]
12. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract][Full Text] [Related]
15. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
16. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.
Genther SM; Sterling S; Duensing S; Münger K; Sattler C; Lambert PF
J Virol; 2003 Mar; 77(5):2832-42. PubMed ID: 12584306
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
18. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.
Lee SJ; Cho YS; Cho MC; Shim JH; Lee KA; Ko KK; Choe YK; Park SN; Hoshino T; Kim S; Dinarello CA; Yoon DY
J Immunol; 2001 Jul; 167(1):497-504. PubMed ID: 11418688
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
20. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Cancer Res; 2003 Jul; 63(13):3478-82. PubMed ID: 12839929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]